3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Feeding Behavior
1
Colorectal Neoplasms
1
Interventions
Specimen Handling
271
Magnetic Resonance Spectroscopy
228
pembrolizumab
219
Carboplatin
180
Cisplatin
146
Biopsy
143
Cyclophosphamide
137
Paclitaxel
128
Nivolumab
117
Gemcitabine
105
Bevacizumab
104
Radiotherapy
86
Dexamethasone
83
Pemetrexed
79
fludarabine
73
Fluorouracil
73
Docetaxel
73
Doxorubicin
72
atezolizumab
71
Radiation
71
Leucovorin
68
Rituximab
65
Oxaliplatin
64
venetoclax
60
Prednisone
59
durvalumab
58
Cetuximab
56
Vincristine
55
Etoposide
54
Lenalidomide
52
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Matrilin Proteins
×
30 days
×
Clear all
NCT04753359
2026-05-27
Bridge CRC
University of Illinois at Chicago
Phase NA
Completed
180 enrolled